William Lewis - 02 Jun 2025 Form 4 Insider Report for INSMED Inc (INSM)

Role
Chair and CEO, Director
Signature
/s/ William Lewis, by Michael A. Smith as Attorney-in-fact
Issuer symbol
INSM
Transactions as of
02 Jun 2025
Net transactions value
-$804,187
Form type
4
Filing time
04 Jun 2025, 16:40:24 UTC
Previous filing
22 May 2025
Next filing
18 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lewis William Chair and CEO, Director 700 US HIGHWAY 202/206, BRIDGEWATER /s/ William Lewis, by Michael A. Smith as Attorney-in-fact 04 Jun 2025 0001402051

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSM Common Stock Options Exercise $74,106 +6,830 +2.9% $10.85 240,754 02 Jun 2025 By the Katie Procter Dynasty Trust F1
transaction INSM Common Stock Sale $70,230 -1,000 -0.42% $70.23 239,754 02 Jun 2025 By the Katie Procter Dynasty Trust F1, F2
transaction INSM Common Stock Sale $313,940 -4,400 -1.8% $71.35 235,354 02 Jun 2025 By the Katie Procter Dynasty Trust F1, F3
transaction INSM Common Stock Sale $102,874 -1,430 -0.61% $71.94 233,924 02 Jun 2025 By the Katie Procter Dynasty Trust F1, F4
transaction INSM Common Stock Sale $391,248 -5,472 -1.7% $71.50 308,758 03 Jun 2025 Direct F5
holding INSM Common Stock 50,500 02 Jun 2025 By the William Lewis Family Legacy Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INSM Stock Option (right to buy) Options Exercise $0 -6,830 -4.2% $0.000000 157,160 02 Jun 2025 Common Stock 6,830 $10.85 By the Katie Procter Dynasty Trust F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 12, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2 This is the weighted average sales price representing 1,000 shares sold at prices ranging from $69.59 to $70.57 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3 This is the weighted average sales price representing 4,400 shares sold at prices ranging from $70.67 to $71.66 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F4 This is the weighted average sales price representing 1,430 shares sold at prices ranging from $71.67 to $72.24 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F5 Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
F6 The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.